Nutraceuticals in the treatment of pulmonary arterial hypertension

11Citations
Citations of this article
94Readers
Mendeley users who have this article in their library.

Abstract

Pulmonary arterial hypertension (PAH) is a severe disease characterized by the loss and obstructive remodeling of the pulmonary arterial wall, causing a rise in pulmonary arterial pressure and pulmonary vascular resistance, which is responsible for right heart failure, functional decline, and death. Although many drugs are available for the treatment of this condition, it continues to be life-threatening, and its long-term treatment is expensive. On the other hand, many natural compounds present in food have beneficial effects on several cardiovascular conditions. Several studies have explored many of the potential beneficial effects of natural plant products on PAH. However, the mechanisms by which natural products, such as nutraceuticals, exert protective and therapeutic effects on PAH are not fully understood. In this review, we analyze the current knowledge on nutraceuticals and their potential use in the protection and treatment of PAH, as well as whether nutraceuticals could enhance the effects of drugs used in PAH through similar mechanisms.

Cite

CITATION STYLE

APA

Sánchez-Gloria, J. L., Osorio-Alonso, H., Arellano-Buendía, A. S., Carbó, R., Hernández-Díazcouder, A., Guzmán-Martín, C. A., … Sánchez-Muñoz, F. (2020). Nutraceuticals in the treatment of pulmonary arterial hypertension. International Journal of Molecular Sciences, 21(14), 1–35. https://doi.org/10.3390/ijms21144827

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free